-
Mashup Score: 2Translational Research and Health Equity: Gene Therapies for Sickle Cell Disease as a Case Study - 16 hour(s) ago
In August of 2023, the National Academies of Science, Engineering, and Medicine published a timely report titled “Toward Equitable Innovation in Health and Medicine: A Framework.” Here, we review som…
Source: onlinelibrary.wiley.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 3Haemoglobin Ottawa, sickle cell trait and vaso‐occlusive crises - 2 month(s) ago
eJHaem is a Gold open access haematology journal of the British Society for Haematology, publishing practice and research papers applicable to a worldwide readership.
Source: onlinelibrary.wiley.comCategories: General Medicine News, Onc News and JournalsTweet-
RT @e_JHaem: Haemoglobin Ottawa, sickle cell trait and vaso-occlusive crises https://t.co/DT4E0SKPkV #SCD @BritSocHaem https://t.co/dLnqC…
-
-
Mashup Score: 4FDA Approves First CRISPR Treatment in U.S. - 4 month(s) ago
Two new therapies—one which uses the gene-editing technology—treat sickle cell anemia.
Source: TIME.comCategories: General Medicine News, Hematologists1Tweet-
Timely article from @TIME (pun intended!) magazine on the first FDA approved CRISPR treatment and it is for #SCD! https://t.co/AZpk3AQFWf
-
-
Mashup Score: 0ASH Clinical News: November 2023 From the Desk Of... - 6 month(s) ago
ASH Clinical News Editor-in-Chief Aaron Gerds, MD, previews the upcoming November 2023 issue of the magazine. Highlights include a feature on gene therapy fo…
Source: www.youtube.comCategories: General Medicine News, Hem/OncsTweet-
Get a first look at the November issue of ASH Clinical News with @AaronGerds! Highlights include a feature on gene therapy for sickle cell disease (#SCD), an AP Voices on the upcoming ASH annual meeting, and more! Stay tuned for publication on November 7! https://t.co/WkR63nJwas
-
-
Mashup Score: 0Changing approaches to the treatment of sudden cardiac arrest - 6 month(s) ago
Preventing sudden cardiac arrest involves managing risk factors such as hypertension, hyperlipidemia and diabetes. We spoke to Christina Albert, MD, about this and much more at ESC 2023.
Source: cardiovascularbusiness.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Video - Christina Albert, MD, Cedars-Sinai, speaks on the changing approaches to sudden cardiac arrest and a Lancet commission looking at ways to improve care through wearable technology and registries #EPeeps @CMAlbertEP #ESC #SCA #SCD https://t.co/2E2inoKXui
-
-
Mashup Score: 7
Andrew James Zapfel, Alexis A. Thompson, Kenneth Bridges, Juliana Richardson, Lwimba Kasongo, Christophe Przybylski, Isaac Odame, Charles Kiyaga, Prebo Barango;
Source: ashpublications.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The new World Coalition on Sickle Cell Disease 🌍 is a public-private partnership aiming to reduce #sicklecell childhood mortality + improve the lives of those w/ #SCD in low-and middle-income countries. More in @BloodAdvances: https://t.co/uSi8cwKkUB #SickleCellAwarenessMonth https://t.co/gn9mymLVjR
-
-
Mashup Score: 6Letter by Figliozzi et al Regarding Article, “The MIDA-Q Mortality Risk Score: A Quantitative Prognostic Tool for the Mitral Valve Prolapse Spectrum” - 7 month(s) ago
Istituto di Ricovero e Cura a Carattere Scientifico Humanitas Research Hospital, Rozzano, Milan, Italy (S.F.). Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece (G.G.). School of Biomedical Engineering and Imaging Sciences, King’s College London, UK (G.G., P-G.M.). School of Biomedical Engineering and Imaging Sciences, King’s College London, UK (G.G., P-G.M.). 1. Essayagh B, Benfari G, Antoine C, Grigioni F, Le Tourneau T, Roussel JC, Bax JJ, Delgado V, Ajmone
Source: www.ahajournals.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Letter to the Editor on the article by Essayagh et al. @CircAHA which developed the MIDA-Q mortality risk score: a prognostic tool for #MVP to intercept patients at increased risk of all-cause death. Does MIDA-Q score capture patients at risk of #SCD? https://t.co/EWx7Uuh7Em
-
-
Mashup Score: 0
Stem cell gene therapy showed significant potential as a curative approach for the hereditary blood disorder sickle cell disease (SCD), according to a recent clinical trial published in the New England Journal of Medicine. According to the study, elevated levels of fetal hemoglobin in red blood cells can mitigate the complications of SCD. Fetal hemoglobin, unlike its adult counterpart, does not polymerize and cause red blood cells to deform under hypoxic conditions. “OTQ923, a clustered regularly interspac
Source: www.docwirenews.comCategories: Latest Headlines, Partners & KOLsTweet-
Stem cell gene therapy showed potential as a curative approach for the hereditary blood disorder sickle cell disease. #hematology #sicklecelldisease #SCD #genetherapy https://t.co/PJPhgsI4sb https://t.co/ASV77BHHE6
-
-
Mashup Score: 2Warning symptoms associated with imminent sudden cardiac arrest: a population-based case-control study with external validation - 8 month(s) ago
The prevalence of warning symptoms was sex-specific and differed significantly between patients with sudden cardiac arrest and controls. Warning symptoms hold promise for prediction of imminent sudden cardiac arrest but might need to be augmented with additional features to maximise predictive power.
Source: www.thelancet.comCategories: Cardiologists, Latest HeadlinesTweet-
Warning symptoms associated with imminent sudden cardiac arrest: a population-based case-control study with external validation https://t.co/4alhMGv0vp @heartscreening #SCD #cardiotwitter @LancetDigitalH
-
-
Mashup Score: 1‘Living life to the fullest:’ Sickle cell gene-editing study at Cleveland Clinic, UH offers hope of pain-free living - 8 month(s) ago
New sickle cell research involves gene-editing technology to target and edit human blood stem cells
Source: www.cleveland.comCategories: Hem/Oncs, Latest HeadlinesTweet-
🙏 @ThePlainDealer for highlighting #genetherapy in #SCD @CleClinic_PHO is committed to providing access to innovative therapies for # SCD ‘Living life to the fullest:’ Sickle cell gene-editing study at @ClevelandClinic, UH offers hope of pain-free living https://t.co/yqMzwkr7yF
-
RT @BCMEthics: New pub from our Dr. Majumder & collab Dr. Fasipe https://t.co/lUN9chxCgO illustrates need in sickle cell disease (#SCD) f…